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INFECTION AFTER CARDIOTHORACIC
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Purpose: To explore morphologic characteristics of choroidal lesions in patients with
disseminated Mycobacterium chimaera infection subsequent to open-heart surgery.
Methods: Nine patients (18 eyes) with systemic M. chimaera infection were reviewed.
Activity of choroidal lesions were evaluated using biomicroscopy, fundus autoﬂuorescence,
enhanced depth imaging optical coherence tomography, ﬂuorescein angiography/indoc-
yanine green angiography, and optical coherence tomography angiography. Relationships
of choroidal ﬁndings to systemic disease activity were sought.
Results: All 9 male patients, aged between 49 and 66 years, were diagnosed with
endocarditis and/or aortic graft infection. Mean follow-up was 17.6 months. Four patients
had only inactive lesions (mild disease). In all ﬁve patients (10 eyes) with progressive ocular
disease, indocyanine green angiography was superior to other tests for revealing new
lesions and active lesions correlated with hyporeﬂective choroidal areas on enhanced
depth imaging optical coherence tomography. One eye with a large choroidal granuloma
developed choroidal neovascularization. Optical coherence tomography angiography
showed areas with reduced perfusion at the inner choroid. All 5 patients with progressive
ocular disease had evidence of systemic disease activity within ±6 weeks’ duration.
Conclusion: Choroidal manifestation of disseminatedM. chimaera infection indicates sys-
temic disease activity. Multimodal imaging is suitable to recognize progressive ocular disease.
We propose ophthalmologic screening examinations for patients with M. chimaera infection.
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Recently,Mycobacterium chimaera, a slowly grow-ing nontuberculous mycobacterium, has attracted
attention because of a global health care–associated
outbreak of invasive infections after cardiothoracic
surgery.1 Currently, over 100 patients from more than
10 countries have been reported to suffer from inva-
sive M. chimaera infection.2–6 These infections re-
sulted from aerosolized M. chimaera originating from
water tanks of heater cooler units used in cardiovas-
cular surgery with extracorporeal circulation for heat-
ing/cooling purposes.1 Because this disease entity is
still relatively unknown, misdiagnosing of clinical
signs seems probable and the actual prevalence of
M. chimaera infection may be substantially higher.4
Clinical and histopathological ﬁndings of ﬁve
patients with ocular M. chimaera infection have been
described recently.7 All ﬁve patients presented with
chorioretinal lesions and a subset of patients had addi-
tional signs of mild anterior uveitis, intermediate uve-
itis, or disc swelling. During follow-up, the number of
chorioretinal lesions was progressive in three of ﬁve
patients despite extensive antimicrobial therapy and
three of ﬁve patients died from complications of dis-
seminated M. chimaera infection.
Because of growing relevance of this health care–
related infection, we herein aim to characterize
choroidal lesions in disseminated M. chimaera infec-
tion of nine patients through multimodal imaging.
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We reviewed differences between active and inactive
ocular ﬁndings. We also tested the hypothesis that
these lesions were related to the systemic affection and
sought relationships to systemic disease activity and
therapy.
Materials, Subjects, and Methods
Case Detection
Methods of case ﬁnding and detection have been
described previously.1,2,7 Brieﬂy, patients had under-
gone open-heart surgery and have subsequently been
diagnosed with M. chimaera infection based on either
positive mycobacterial tissue cultures, 16SrRNA PCR,
or mycobacterial blood cultures. Ocular ﬁndings were
collected at baseline of M. chimaera diagnosis and
during prospective follow-up. For the current study,
ophthalmologic ﬁndings of the patients treated at the
University Hospital Zurich were completed, and sup-
plemented by four additional cases of disseminated
M. chimaera infections with ocular involvement from
the University Hospital Basel. Institutional review
board approval was obtained and all patients provided
informed consent to publish their clinical data.
Clinical Aspects
Patients with disseminated M. chimaera infection
were initially treated with a 4- or 5-fold tuberculostatic
therapy containing clarithromycin, ethambutol, rifabu-
tin, and moxiﬂoxacin ± amikacin with the goal of an
early redo surgery with replacement of all cardiac for-
eign material if possible (Table 1). At the time of redo
surgery and during clinical follow-up, blood and tissue
cultures for mycobacteria were obtained. Systemic dis-
ease activity was deﬁned as new positive blood cultures
for mycobacteria and/or new positive mycobacterial
cultures from a normally sterile site either while on
tuberculostatic therapy (breakthrough infection) or in
the posttreatment period (relapse).
Assessment of Ocular Findings and Acquisition of
Multimodal Imaging Findings
Patients underwent a complete ophthalmologic
examination including biomicroscopy, color fundus
photography with ultra-wideﬁeld photography using
Optomap scanning laser ophthalmoscope (Optos,
Marlborough, MA), spectral domain optical coherence
tomography (OCT) including enhanced depth imaging
(EDI) technique, fundus autoﬂuorescence (FAF) imag-
ing, ﬂuorescein angiography/indocyanine green angiog-
raphy (FA/ICGA) and, where possible, OCT
angiography (OCTA). The wideﬁeld angiograms were
either obtained using the Optomap system or the ultra-
wideﬁeld module for the Heidelberg SPECTRALIS
HRA + OCT.8 The spectral domain OCTs and EDI-
OCTs were obtained using the Heidelberg SPECTRA-
LIS (version 1.9.10.0) as viewed with the contained Hei-
delberg software (Spectralis Viewing Module 6.0.9.0;
Heidelberg Engineering, Heidelberg, Germany). In this
study, at least 31 B-scans were obtained within a 20° ·
25° rectangle centered on the macula; however, the scan
pattern was adapted according to the location and the
size of the lesions. Choroidal imaging was obtained
using the same instrument in the EDI mode.9 Fundus
autoﬂuorescence images were obtained in all patients
using the confocal scanning laser ophthalmoscope
(Heidelberg Retinal Angiograph, HRA2; Heidelberg
Engineering). Optical coherence tomography angiogra-
phy images were obtained using PLEX Elite 9000
swept-source OCT (Carl Zeiss Meditec, Inc., Dublin,
CA) with OMAGc algorithm.10 The scan area for this
study was a 12 mm · 12 mm scan centered on the fovea
and around the posterior pole to create a wideﬁeld mon-
tage image obtained with each cube consisting of 2
repeated volumes of 500 B-scans. We used the preset
segmentation of the viewing software to extract the outer
retina/choriocapillaris slab, which extends from 110 mm
above retinal pigment epithelium (RPE) to 38 mm below
RPE. In case of neovascular lesions, we used, in addi-
tion, a 3 · 3 scan centered on the lesion and we included
the outer retina slab to better detect the neovascular
membrane located above the RPE.
After diagnosis of ocular involvement, eye exami-
nations were warranted every 3 to 4 months or more
frequently if required, including regular multimodal
imaging acquisition. Three readers (C.B., S.A.Z., and
M.A.-S.) reviewed the spectrum of imaging ﬁndings in
all cases. “Progressive ocular disease” was deﬁned as
occurrence of two or more new chorioretinal lesions
per eye if they were not present in previous examina-
tions and/or enlargement of previously existing
choroidal lesions. The time between diagnosis of “pro-
gressive ocular disease” and “active systemic disease”
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Table 1. Characteristics of Patients With Disseminated M. chimaera Infection and Relationships Between Ocular and
Systemic Disease
Characteristics
Cases
2 3 4 5
Sex Male Male Male Male
Age (years) 51 64 49 61
Infection
Time between index
surgery and
diagnosis
1 year 4 months 3 years 3 months 3 years 5 months 1 year 9 months
Treatment
Tuberculostatic
treatment
Clarithromycin Clarithromycin Clarithromycin Clarithromycin
Ethambutol Ethambutol Ethambutol Ethambutol
Rifabutin Rifabutin Rifabutin Rifabutin
— Moxiﬂoxacin Moxiﬂoxacin Moxiﬂoxacin
— Amikacin Amikacin Amikacin
Duration of
tuberculostatic
treatment from
diagnosis to redo
surgery, days
na 365 days 0 days 240 days
Redo surgery na* Replacement of mitral
annuloplasty ring by
bio mitral valve
Replacement of
mechanical aortic
valve by aortic root
bio
Aortic root and arch
replacement
Initial ocular ﬁndings Multifocal
choroiditis
Mild ocular
abnormalities
Mild ocular
abnormalities
Multifocal choroiditis
Outcome
Ocular disease Progressive
choroiditis (active)
Choroidal lesions stable
(inactive)
Progressive choroiditis
(active)
Progressive
choroiditis (active)
Follow-up of
ophthalmologic
monitoring (months)
1 47 51 8
Signs of systemic
disease activity at
diagnosis of
progressive
choroiditis†
Yes na Yes Yes
Implications of
chorioretinitis on
tuberculostatic
treatment
na No Treatment ongoing na
Death Yes No No Yes
Healed na Yes na na
Relapse na No Yes na
Breakthrough
infection
Yes No Yes Yes
Characteristics
Cases
6 7 8 9 10
Sex Male Male Male Male Male
Age (years) 63 64 66 50 58
Infection
Time between
index surgery
and diagnosis
1 year 10
months
1 year 9 months 3 years 2 years 2 months 2 years and 1
month
Treatment
(continued on next page)
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Table 1. (Continued )
Characteristics
Cases
6 7 8 9 10
Tuberculostatic
treatment
Clarithromycin Clarithromycin Clarithromycin Clarithromycin Clarithromycin
Ethambutol Ethambutol Ethambutol Ethambutol Ethambutol
Rifabutin Rifabutin Rifabutin Rifabutin Rifabutin
Moxiﬂoxacin Amikacin Moxiﬂoxacin Moxiﬂoxacin Moxiﬂoxacin
— — — Amikacin Amikacin
Duration of
tuberculostatic
treatment from
diagnosis to redo
surgery, days
10 days 91 days 70 days 132 days 98 days
Redo surgery Rethoracotomy Replacement of bio
aortic valve by
aortic root
homograft
Replacement of bio
aortic composite
graft) by
combined aortic
valve and aorta
ascendens
homograft
Replacement of
mitral valve
annuloplasty
Replacement of
aortic root and
aortic arch by
a homograft and
bovine
pericardium
tube,
respectively
Debridement Epicardial PM
implantation
Replacement of
endovascular
PM by epicardial
PM
Graft retention
Initial ocular
ﬁndings
Multifocal
choroiditis
Multifocal
choroiditis
Multifocal
choroiditis
Mild ocular
abnormalities
Mild ocular
abnormalities
Outcome
Ocular disease Progressive
choroiditis
(active)
Choroidal lesions
stable (inactive)
Progressive
choroiditis
(active)
Choroidal lesions
stable (inactive)
Choroidal lesions
stable (inactive)
Follow-up of
ophthalmologic
monitoring
(months)
13 14 10 9 6
Signs of
systemic disease
activity at
diagnosis of
progressive
choroiditis†
Yes na Yes na na
Implications of
chorioretinitis on
tuberculostatic
treatment
na Treatment ongoing Treatment ongoing Treatment ongoing Treatment ongoing
Death Yes No No No No
Healed na na na na na
Relapse na na na na na
Breakthrough
infection
Yes No Yes No no
*na, not applicable.
†Systemic disease activity was deﬁned as new positive blood cultures for mycobacteria and/or new positive mycobacterial cultures
from a normally sterile site either while on tuberculostatic therapy (breakthrough infection) or in the posttreatment period (relapse).
4 RETINA, THE JOURNAL OF RETINAL AND VITREOUS DISEASES  2017  VOLUME 0  NUMBER 0
Copyright ª by Ophthalmic Communications Society, Inc. Unauthorized reproduction of this article is prohibited.
was assessed. For classiﬁcation of uveitis, criteria of
the Standardization of Uveitis Nomenclature Working
Group were applied.11 Enhanced depth imaging OCT
scans over the choroidal lesions were evaluated
regarding full thickness/partial thickness, shape, reﬂec-
tivity, internal pattern, margins, and hypertransmis-
sion. In adddition, the presence of any ﬂuid was
noted using spectral domain OCT. The en face image
of the choriocapillaris was used to visualize the le-
sions. The OCTA image was registered to the ICGA
image using the publically available ImageJ software
(public domain software; National Institutes of Health,
Bethesda, MD) as described previously.12 For this pur-
pose, the choriocapillaris OCTA image and the ICGA
were registered to each other using vascular bifurca-
tion in the superﬁcial plexus as landmark to align the
two images for accurate comparison. Changes in the
choriocapillaris/inner choroid perfusion were identi-
ﬁed. Presence of a neovascular ﬂow/membrane in
the avascular outer retina and/or sub-RPE space was
evaluated.
Results
Patient Characteristics
Nine white patients (18 eyes) aged between 49 and
66 years were diagnosed with either endocarditis and/
or aortic graft infection with M. chimaera after a car-
diothoracic surgery with extracorporeal circulation.
Fig. 1. Multimodal imaging of
active ocular disease in dissem-
inated M. chimaera infection.
Ultra-wideﬁeld photography (A)
and conventional fundus pho-
tography (B) show multiple
roundish chorioretinal lesions.
Most of the lesions show an
indistinct border indicating
active disease (white arrows),
whereas others have well-
deﬁned borders and represent
atrophic scars of formerly active
lesions (arrowheads). The le-
sions typically show hyper-
ﬂuorescence in ﬂuorescein
angiography (C) and hypo-
cyanescence in indocyanine
green angiography (D). Fundus
autoﬂuorescence (E) indicates
both hyperautoﬂuorescent and
hypoautoﬂuorescent areas.
Enhanced depth imaging OCT
(F) of an active chorioretinal
lesion; note the full-thickness
hyporeﬂectivity leading to focal
choroidal thickening (white
arrows).
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All patients had a negative serology for HIV. All eyes
had bilateral chorioretinal lesions. Applicable patient
numbers were maintained according to previous pub-
lications.2,7 Table 1 shows clinical characteristics of
each patient including medical and surgical treatment.
Mean ophthalmologic follow-up was 17.6 months. All
nine patients were discovered prospectively by screen-
ing patients with known infections. At baseline, two
patients reported blurred vision, whereas seven pa-
tients had no visual symptoms. During follow-up,
two initially symptom-free patients described
decreased vision and blurriness correlating with pro-
gressive ocular ﬁndings. Morphology of the choriore-
tinal lesions in these patients are described in more
detail by assessing each imaging technique separately.
Multimodal Imaging Findings of Choroidal Lesions
Fundus photography. Despite the fact that all
patients had chorioretinal lesions as seen using fundus
Fig. 2. Progression from inactive to active ocular disease in disseminated M. chimaera infection. A–C. Fundus photography (A, right eye; B, left eye)
and indocyanine green angiography (C, left eye) of a 50-year-old patient who was diagnosed ad redo surgery. Few clinically inactive lesions were
observed to be stable for over 20 months. Systemic antimycobacterial therapy was stopped after 24 months as the infection was deemed clinically
inactive. D–F. The same patient was hospitalized 15 months later due to worsening hepatic function consistent with atypical mycobacteremia and
consecutively diagnosed with a relapse based on positive mycobacterial blood cultures. In conjunction with the relapse, progression of choroidal lesions
was observed. G–I. Five months later, despite systemic antimycobacterial treatment, more lesions became clinically evident.
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photography or using biomicroscopy, the extent of
these lesions varied widely. At baseline, four patients
had only a very few inactive (2–5/eye) choroidal le-
sions (mild ocular abnormalities). During follow-up,
ﬁve patients (10 eyes) developed widespread lesions
(progressive ocular disease). The lesions had typically
a round or ovoid shape (Figures 1–4). Figure 1 shows
an exemplary overview of active ocular disease in
different patients using different multimodal imaging
methods. Although these white-yellowish lesions were
usually small (50–300 mm diameter), their size was
observed to increase over weeks in active disease.
An example of progressive disease over time is shown
in Figure 2. Furthermore, indistinct borders on fundus
photography represented a sign of activity, whereas
inactivity or quiescence was related to well-deﬁned
borders of the lesions (Table 2). The largest lesion in
the cohort had a diameter of 2,700 mm (Figure 5). In
patients with progressive ocular disease, the number of
lesions was increasing over 4 to 8 weeks and lesions
were ultimately distributed diffusely over both the pos-
terior pole and the retinal periphery. All ﬁve patients
with new lesions and, therefore, active ocular disease
also showed atrophic lesions suggesting formerly
active lesions (Figure 1). Active and inactive lesions
could be observed in close proximity in the same eye.
In 3 of 5 patients with progressive ocular disease, we
were able to detect a stable period with clinically inac-
tive lesions over at least 6 months before progression
to active ocular disease.
Fluorescein angiography. Active choroidal lesions
in all ﬁve patients with progressive disease were
initially hypoﬂuorescent on FA, with staining in the
later frames (Figures 1 and 4). However, early phase of
FA showed hyperﬂuorescence of inactive lesions with
hyperﬂuorescence in late phase according to a window
defect. In two patients (four eyes) with progressive
disease, FA also indicated a mild optic disk leakage.
Otherwise, no obvious angiographic features could be
observed. No eye had signs of retinal vasculitis, of
capillary nonperfusion, or of cystoid macular edema.
Indocyanine green angiography. By ICGA, there
were multiple hypocyanescent lesions, which were
found to be hypocyanescent in both early and late
frames. As compared to other means of investigation,
the lesions detected on ICGA outnumbered the lesions
detected on fundus photography or FA by .5 per eye
in all 10 eyes with progressive disease (Figures 2 and
4). In all cases, ICGA was, therefore, superior to fun-
dus photography for assessing occurrence of new
Fig. 3. Examples of choroidal lesions by EDI-OCT examination and in correlation with fundus photography (middle column) and ICGA (right
column). In the active form of the disease (A and D), the borders of the lesion on EDI-OCT were found to be relatively well-deﬁned because there
usually was an intense homogenously hyporeﬂective area (arrows). G. Note the borders of this inactive lesion, which were poorly deﬁned (arrowheads).
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lesions. Large active lesions showed a longer and
stronger hypocyanescence in the late phase of the IC-
GA than inactive lesions. However, even after more
than 6 months’ duration, lesions still showed a faint
hypocyanescence. Complete regression of the hypo-
cyanescent areas was not observed, even in clinically
quiet and sharply demarcated lesions on fundus pho-
tography, which could be explained because of atro-
phy of the choriocapillaris/stromal choroid.
Fundus autoﬂuorescence. Using FAF, active cho-
rioretinal lesions presented as hyperautoﬂuorescent
areas in all ﬁve patients with progressive disease
(Figure 1). In the inactive status of the lesion, they
appeared typically hypoautoﬂuorescent. Frequently,
new active hyperautoﬂuorescent lesions could be
observed close to atrophic hypoautoﬂuorescent le-
sions. Lesions in the very late stages often showed
a conﬂuent hypoautoﬂuorescence indicating conﬂuent
loss of RPE cells. Between lesions, the FAF was found
to be normal without presence of pathologic hyper-
autoﬂuorescence or hypoautoﬂuorescence. However,
lesions on FAF were outnumbered by lesions found
on ICGA by .5 per eye in all cases with progressive
disease.
Fig. 4. Multimodal imaging and
en face OCTA of chorioretinal
lesions. A. Fundus color pho-
tography of the left eye demon-
strating different-sized white-
yellowish chorioretinal lesions
(arrows) involving the posterior
pole. B. Late-frame FA demon-
strating few hyperﬂuorescent
lesions throughout the posterior
pole and the middle periphery.
C. Indocyanine green angiogra-
phy shows multiple hypo-
cyanescent lesions. D. En face
OCTA image of the chorioca-
pillaris demonstrates multiple
areas of ﬂow reduction at the
site of the lesions comparable
with the ICGA. Note the out-
numbered lesions compared
with the FA (arrowheads).
Table 2. Classiﬁcation of Choroidal Lesions Based on Multimodal Imaging
Imaging Modality Active Lesion
Inactive Lesion/Lesion in
Regression
Fundus photography
Shape Ovoid to round Ovoid to round
Border Indistinct Well-deﬁned
Size Small (,1 disk diameter) Small (,1 disk diameter)
Color Yellow-white Whitish
FA
Early Hypoﬂuorescent Hyperﬂuorescent
Late Hyperﬂuorescent Hyperﬂuorescent
ICGA Hypoﬂuorescent Hypoﬂuorescent
FAF Hyperautoﬂuorescent Hypoautoﬂuorescent
EDI-OCT
Shape Full-thickness, round, well-deﬁned
borders
Poorly deﬁned margins
Internal reﬂectivity Hyporeﬂective Similar to the choroid
Increased transmission effect Present Present
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Enhanced depth imaging ocular coher-
ence tomography. Enhanced depth imaging OCT
revealed full-thickness, round hyporeﬂective areas
with markedly reduced choroidal vascularity in all
10 eyes with progressive disease (Figure 3). The bor-
ders of active lesions on EDI-OCT were found to be
relatively well deﬁned as there usually was an intense
homogenously hyporeﬂective area. Inactive lesions
did not always correlate with a substantial hyporeﬂec-
tive area. Therefore, the borders of inactive lesions
were generally poorly deﬁned (Figure 3). Full-
thickness lesions were shown to affect the adjacent
RPE, in such as that the latter was attenuated and
irregularly shaped. Smaller, partial-thickness lesions
were also present in at least some cases, but because
of the smaller size, they were more difﬁcult to verify.
Hypertransmission was observed in both inactive and
active lesions (Figure 3). Enhanced depth imaging
OCT revealed that even alterations of the integrity of
the ellipsoid zone were present over choroidal lesions
(Figure 3). The size of active lesions was observed to
decrease over time, whereas new lesions developed
near the latter lesion. One progressively large granu-
loma has led to a Type 2 macular neovascularization
with development of subretinal ﬂuid above the cho-
rioretinal lesion (Figure 5).
Optical coherence tomography angiography. Opti-
cal coherence tomography angiography was performed
Fig. 5. Fundus photography
(A), ﬂuorescein angiography
(C), and EDI-OCT (B and D) of
a large, full-thickness choroidal
granuloma (white arrows) with
presence of active choroidal
neovascularization. Note the
presence of subretinal ﬂuid and
subretinal hyperreﬂective mate-
rial. Also, the choroid is mark-
edly thickened (white arrows).
Fig. 6. Neovascular lesion
before and after treatment with
anti-VEGF. The left eye of this
patient presented with a large
chorioretinal lesion involving
the posterior pole. Features of
neovascularization were seen on
structural OCT including sub-
retinal hyperreﬂective material.
In the OCTA including the en
face image of the chorioca-
pillaris and the avascular outer
retina, neovascular ﬂow with
small- and medium-caliber ves-
sels with branching of tiny ves-
sels and arcades at the vessel
termini (A) was observed. The
right image shows the lesion 4
weeks after treatment with anti-
VEGF. Note the reduced retinal
thickness on the structural OCT,
the decreased hyperreﬂective
material, and the reduced area of
the neovascular lesion (white
arrows, B).
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in one patient with progressive disease and in three
patients with mild ocular disease. In progressive
disease, the choriocapillaris/inner choroid en face
OCTA image showed a ﬂow reduction in the area
that corresponded to the detected lesions on ICGA
(Figure 4). Interestingly, the lesions detected by
OCTA also outnumbered those found by both fundus
photography and FA. The en face and cross-sectional
OCTA image of a patient who reported blurry vision
showed neovascular ﬂow overlying a large chorioreti-
nal lesion involving the posterior pole. The subretinal
hyperreﬂective material (SHRM) detected on the struc-
tural OCT corresponded with neovascular ﬂow pre-
sented on the en face OCTA image of the avascular
outer retina/choriocapillaris (Figure 6). Morphologi-
cally, the lesions showed small- and medium-caliber
vessels with branching of tiny vessel and arcades at the
vessel termini. Intravitreal anti–vascular endothelial
growth factor (anti-VEGF) treatment was performed,
leading to marked regression of the neovascularization
activity. Best-corrected visual acuity in the affected
eye increased from 20/25 before therapy to 20/20 after
treatment. The follow-up visit 4 weeks after anti-
VEGF therapy showed a reduced retinal thickness,
decreased SHRM, and reduced area and density of
the neovascular membrane.
Relationship to Systemic Disease Activity
Table 1 shows relationships between ocular and sys-
temic disease for each patient. In ﬁve of nine patients,
progression of the number and size of choroidal le-
sions was observed despite being under systemic anti-
microbial therapy. As of September 2017, 3 of these 5
patients have died because of systemic complications,
potentially related to uncontrolled M. chimaera infec-
tion.2,7 In four patients with progressive disease, redo
surgery was either not performed or performed very
late in the disease process or parts of the cardiovascu-
lar materials were retained (Cases 2, 4, 5, and 6). In
one patient (Case 8), a breakthrough infection (posi-
tive blood cultures, new mycobacterial spinal lesions)
was diagnosed 8 months after redo surgery and ongo-
ing antimicrobial therapy. All 5 patients had evidence
of systemic disease activity within ±6 weeks before or
after the diagnosis of progressive choroiditis. In three
patients, the ocular progression preceded systemic dis-
ease activity, whereas in two patients, systemic disease
activity was diagnosed before ocular progression.
Discussion
Choroidal manifestation seems to be an accessible
indicator of systemic disease activity in patients with
disseminated M. chimaera infection. This study high-
lights the description and evolution of the chorioretinal
lesions using various multimodal imaging techniques.
Two particular aspects of ocular involvement were the
uniform distribution and the extensive number of cho-
roidal lesions despite antimycobacterial treatment.
Monitoring disease activity in patients with dissemi-
nated M. chimaera disease should not be based on
color fundus photography or biomicroscopy alone. In-
docyanine green angiography is superior to assess the
occurrence of new lesions, whereas EDI-OCT is suit-
able to visualize details of the choroidal lesions. Mul-
timodal imaging is helpful for classifying lesions as
active or inactive, for assessing the response to anti-
microbial treatment, and for detecting early subclinical
recurrences.
Enhanced depth imaging OCT allows for an assess-
ment of structural choroidal abnormalities. In patients
with M. chimaera infection, EDI-OCT scanning nicely
indicated the size and the extent of hyporeﬂective le-
sions. The normal choroidal vascularity was markedly
reduced in the affected area and we were able to dem-
onstrate that clinically active lesions were mostly
involving the full choroidal thickness extending from
the back of the RPE to the choroidoscleral border.
However, the lesions are generally not limited to the
choroidal space, but often affect the RPE and some-
times also the outer retinal layers. These hyporeﬂective
areas became less prominent over time and the initial
homogenous hyporeﬂectivity gradually decreased.
Histopathological investigation of these lesions in
one affected subject revealed local granulomatous
inﬂammation.7 The presence of mycobacteria has also
been hypothesized, but could not be proven, probably
because of their fastidious growth.
Although EDI-OCT was suitable to monitor
selected lesions, imaging with ICGA enabled a better
global visualization of lesions, including central and
peripheral areas. Hypocyanescent lesions on ICGA
outnumbered lesions on fundus photography and on
FAF, indicating that only a subset of the total
choroidal lesions were either large enough or localized
close enough to the RPE to be visualized by photog-
raphy or FAF. These spots could result from blockage
by the lesions themselves, from choroidal hypoperfu-
sion or from displacement of vessels by space-
occupying lesions. Under systemic anti-infective ther-
apy, some lesions were observed to become less
hypocyanescent but they did not completely disappear.
However, this change is not proven to be treatment
related and might also reﬂect disease evolution.
Because all patients with active disease were system-
ically treated, the clinical course of active lesions
without treatment is not clear. Our data showed that
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regression of one single lesion did not necessarily
correlate with the overall disease control because
sometimes new lesions developed in the proximity
and signiﬁcantly increased in size. This might be
explained by recurrent bacteremia that led to new
lesions, whereas older ones were becoming smaller
and atrophic after a few weeks under treatment.
The biomicroscopic presentation of the chorioretinal
lesions in our series was similar to that of multifocal
choroiditis related to ocular tuberculosis.13–19 How-
ever, besides similarities there also seem to be differ-
ences between the two entities. The M. chimaera–
related lesions were all roundish, whereas the cho-
rioretinal lesions in tuberculosis are generally more
variable in shape. Fundus imaging of ocular tubercu-
losis may show a more irregularly distribution com-
pared with the picture in M. chimaera infection. Also,
although there is a large spectrum of ﬁndings in ocular
tuberculosis, none of the patients in these series pre-
sented with other ﬁndings potentially suggestive of
tuberculosis such as nodular scleritis, interstitial ker-
atitis, synechia, severe vitritis, serpiginoid choroiditis,
or retinal vasculitis.19 Choroidal lesions observed in
tuberculosis usually resolve under systemic treatment
over a few weeks, with residual scarring.18,20
However, nontuberculous mycobacterium infections
in and around the eye are clinically recalcitrant and
may require long-term therapy and removal of
biomaterials.21
M. chimaera–related choroiditis has not been
described speciﬁcally before this current outbreak.
However, other atypical mycobacteria have been re-
ported to cause choroiditis, namely in HIV-positive
patients.22,23 Bhikoo et al have described such a case
of multifocal choroiditis in an HIV patient with dis-
seminated M. avium complex infection. The choroidal
lesions in this subject were larger compared with the
lesions in our HIV-negative M. chimaera patients.
Multifocal choroiditis has also been reported as initial
manifestation of disseminated cryptococcal infec-
tion.24 Andreola et al25 have described Cryptococcus
neoformans infection and multifocal choroiditis in an
HIV patient, which led to blindness. The clinical pre-
sentation in these cases was similar as the multifocal
choroiditis in patients with M. chimaera infection.
The development of choroidal neovascularization
(CNV) in the setting of an active granuloma is
intriguing. Although infrequently, CNV has been
reported in eyes with infectious chorioretinitis includ-
ing tuberculosis, toxoplasmosis, syphilis, presumed
ocular histoplasmosis syndrome, and Bartonella hen-
selae.26–32 However, in most of these cases, CNV pre-
sented not during the acute inﬂammatory process, but
later in the setting of a chorioretinal scar. The differ-
entiation between inﬂammatory-related structural al-
terations and neovascular lesions presenting as
SHRM is by spectral domain OCT usually difﬁcult
and may result in delayed treatment. Optical coherence
tomography angiography, a relatively new noninva-
sive technique, permits detection of vascular ﬂow/net-
works relative to tissue depth and allows to distinguish
vascular and avascular SHRM.33 In our patient, neo-
vascular ﬂow in the subretinal space located over the
granuloma could be clearly demonstrated on OCTA
despite minimal leakage on FA. Optical coherence
tomography angiography allowed not only to detect
but also to monitor the response to treatment in dis-
seminated M. chimaera infection with NV.
During prospective follow-up of these nine patients,
we have observed progression in ﬁve patients and
activation of previously inactive ocular disease in at
least three patients so far. Because ocular disease
likely reﬂects systemic disease activity, monitoring is
highly recommended (Table 3). To provide accurate
care, we herein propose baseline and follow-up eye
examinations for patients at risk of M. chimaera infec-
tion. These recommendations were based on our ob-
servations including the aforementioned relationships
between ocular and systemic progression and the fact
that new lesions developed within 4 to 8 weeks. The
generalizability of these recommendations is limited
by the fact that this infection is overall uncommon
and clinical experience is scarce. The low incidence
of this infection also explains the relatively small sam-
ple size, which is a limitation of the study. The follow-
up duration differs between patients and longer obser-
vation periods may show different or new insights.
Interpretation of relationships between ocular and sys-
temic ﬁndings is confounded by temporary diagnostic
windows of both ophthalmologic imaging ﬁndings and
systemic activity signs such as blood cultures.
In conclusion, in patients with bilateral multifocal
choroiditis and a history of cardiothoracic surgery,
disseminated M. chimaera infection should be sus-
pected. Differentiating between active and inactive
ocular disease by multimodal imaging is important
because of the likely association with systemic disease
activity. Thorough clinical examination, fundus pho-
tography, and EDI-OCT can detect the presence of
active chorioretinal lesions, whereas FA and especially
ICGA reveal the total lesion number and are better
suited to detect overall disease progression. Optical
coherence tomography angiography showed ﬂow
reduction at the level of choriocapillaris/inner choroid
that corresponded to the lesions detected on ICGA.
Whether this ﬁnding represents hypoperfusion of the
choriocapillaris or displacement of the capillaries by
space-occupying lesions needs to be investigated in
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the future. Furthermore, analysis of en face OCTA and
cross-sectional OCTA images enabled detection of
neovascular ﬂow secondary to CNV and its response
to treatment with anti-VEGF.
Key words: spectral domain optical coherence
tomography, fundus autoﬂuorescence, multifocal cho-
roiditis, choroidal tubercles, granulomatous choroidi-
tis, nontuberculous mycobacterial infection,
Mycobacterium chimaera, mycobacterium avium
complex, cardiac surgery.
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